Cost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly People
JAMAPublished 22 October 1997
Jane E. Sisk
Citations355
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Pneumococcal vaccination saves costs in the prevention of bacteremia alone and is greatly underused among the elderly population, on both health and economic grounds, and supports recent recommendations of the Advisory Committee on Immunization Practices.
Abstract
Pneumococcal vaccination saves costs in the prevention of bacteremia alone and is greatly underused among the elderly population, on both health and economic grounds. These results support recent recommendations of the Advisory Committee on Immunization Practices and public and private efforts under way to improve vaccination rates.
Keywords
MedicineEconomics, Econometrics and Finance
Cost-Effectiveness in Health and Medicine
7,119 Citations1996
New England Journal of MedicineFoundations of Cost-Effectiveness Analysis for Health and Medical Practices
2,140 Citations1977Milton C. Weinstein, William B. Stason
PubMedHow attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
1,586 Citations1992A. Laupacis, David Feeny +2 more
Four "levels of evidence" that rate economic evaluations on the basis of their methodologic rigour are proposed, based on the quality of the methods used to estimate clinical effectiveness, quality of life and costs.
PubMedState- and sex-specific prevalence of selected characteristics--Behavioral Risk Factor Surveillance System, 1996 and 1997.
1,110 Citations2000Deborah Holtzman, Eve Powell‐Griner +2 more
The 1996 and 1997 BRFSS data demonstrate that U.S. adults engage in behaviors that are detrimental to their health, but also demonstrate that many adults are making efforts to prevent chronic disease and injury.
New England Journal of MedicineThe Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
1,062 Citations1991Eugene D. Shapiro, Anne T. Berg +6 more
Polyvalent pneumococcal vaccine is efficacious in preventing invasive pneumitiscal infections in immunocompetent patients with indications for its administration and should be used more widely.
PsycEXTRA DatasetPrevention of Pneumococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1,007 Citations1997
This report updates the last recommendations by the Advisory Committee on Immunization Practices concerning pneumococcal polysaccharide vaccine and contains updated information regarding a) antimicrobial resistance among pneumococci, b) vaccine effectiveness and cost-effectiveness, c) indications for vaccination, d) guidelines for revaccination, e) strategies for improving delivery of vaccine, and f) development of pneumitiscal conjugate vaccine.
New England Journal of MedicineThe Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the Community
1,004 Citations1994Kristin L. Nichol, Karen L. Margolis +2 more
For elderly citizens living in the community, vaccination against influenza is associated with reductions in the rate of hospitalization and in deaths from influenza and its complications, as compared with the rates in unvaccinated elderly persons, and vaccination produces direct dollar savings.
Medical Decision MakingProbabilistic Sensitivity Analysis Using Monte Carlo Simulation
841 Citations1985Peter M. Doubilet, Colin B. Begg +3 more
This paper describes a practical method for probabilistic sensitivity analysis, in which uncertainties in all values are considered simultaneously, and a parametric model that permits each distribution to be specified by two values: the baseline estimate and a bound of the 95 percent confidence interval.
JAMAPneumococcal Polysaccharide Vaccine Efficacy
631 Citations1993Jay C. Butler
Intensified efforts to improve pneumococcal vaccine coverage among certain populations for whom vaccination is currently recommended is indicated, but universal revaccination is not warranted at this time.
JAMAEmergence of Drug-Resistant Pneumococcal Infections in the United States
551 Citations1994Robert F. Breiman
Current recommendations for use of 23-valent pneumococcal capsular polysaccharide vaccines should be aggressively promoted and that development and evaluation of new conjugate pneumococCal vaccines may be a crucial part of strategies for prevention are suggested.
New England Journal of MedicineThe Prevalence of Drug-Resistant<i>Streptococcus pneumoniae</i>In Atlanta
510 Citations1995J. Hofmann, Martín S. Cetron +6 more
Control of drug-resistant pneumococci will require more judicious use of antimicrobial agents and wider use of the pneumococcal polysaccharide vaccine.
New England Journal of MedicineEfficacy of Pneumococcal Vaccine in High-Risk Patients
399 Citations1986Michael S. Simberkoff, Anne Cross +9 more
The data suggest that chronically ill patients, who are most susceptible to infection, may have an impaired immune response to the pneumococcal vaccine.
Annals of Internal MedicineThe Clinical Effectiveness of Pneumococcal Vaccine in the Elderly
322 Citations1988RICHARD V. SIMS, WILLIAM C. STEINMANN +4 more
The clinical effectiveness ofneumococcal vaccine in preventing pneumococcal infection in the immunocompetent elderly approximates the vaccine's effectiveness in the general immunocmpetent population.
Annals of Internal MedicineImmunization Policies and Vaccine Coverage Among Adults
305 Citations1988Walter W. Williams, MEREDITH A. HICKSON +4 more
Vigorous efforts are needed to implement strategies to reduce disease incidence, morbidity, and death among adults.
Management ScienceDiscounting of Life-Saving and Other Nonmonetary Effects
278 Citations1983Emmett B. Keeler, Shan Cretin
JAMABacteremia With Streptococcus pneumoniae
255 Citations1996Joseph F. Plouffe
Increased use of pneumococcal vaccine and recognition of antimicrobial resistance patterns may assist physicians in treating patients withS pneumoniaebacteremia.
Archives of Internal MedicinePneumococcal Bacteremia in Charleston County, South Carolina
210 Citations1990Robert F. Breiman
The findings emphasize the need for effective programs promoting use of pneumococcal vaccine in high-risk groups, particularly those more than or equal to 65 years old, and the development of a more immunogenic vaccine for children less than 2 years old.
PsycEXTRA DatasetYears of Healthy Life
182 Citations1995Pennifer Erickson, Ronald S. Wilson +1 more
The years of healthy life (YHL) concept has emerged as one of the more commonly used health status measures that include both mortality and morbidity.
The American Journal of MedicineInefficacy of pneumococcal vaccine in a high-risk population
174 Citations1987Harriet Forrester, Dennis W. Jahnigen +1 more
Pneumococcal vaccine did not appear to be protective in this high-risk population of patients, and serotype distribution should be different in vaccinated and nonvaccinated bacteremic patients.
Archives of Internal MedicinePreventing Pneumococcal Bacteremia in Patients at Risk
174 Citations1995Barry M. Farr
The development of antibiotic-resistant Streptococcus pneumoniae indicates an urgent need for an increased rate of vaccination among high-risk patients and for the development of more immunogenic conjugate vaccines that may enhance efficacy among elderly and immunocompromised patients as well as infants.
New England Journal of MedicineCost Effectiveness of Vaccination against Pneumococcal Pneumonia
158 Citations1980Jane Sisk Willems, Claudia R. Sanders +2 more
JAMAInfluenza Vaccination
154 Citations1983Michael A. Riddiough
The analysis indicates the need for epidemiologic research on the extent of influenza and the mechanism of its spread and raises the issue of public policy to promote influenza vaccination among high-risk persons as a low-cost, preventive technology.
Annals of Internal MedicineCost Effectiveness of Vaccination Against Pneumococcal Pneumonia: An Update
148 Citations1986Jane E. Sisk, RICHARD K. RIEGELMAN
Current levels of vaccination appear too low considering the potential health benefits and cost-effectiveness, and the low estimates of 10% of pneumonia as pneumococcal and a 3-year duration of immunity now appear more likely.
PubMed[Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions].
117 Citations1985J. Gaillat, D Zmirou +6 more
The incidence of pneumonia was significantly reduced in the vaccinated group but the mortality rate was not modified, and the concluded in favor of the effectiveness of pneumococcal vaccine: etiological fraction 77.1% (51.2%-89.3% confidence limits, 95% risk).
PubMedTentative guidelines for using clinical and economic evaluations revisited.
113 Citations1993A. Laupacis, David Feeny +2 more
Comments cover the appropriateness of quality-adjusted lifeyears (QALYs) as a measure of outcome in economic evaluations and the potential adverse consequences of using tentative guidelines on clinical and economic evaluations.
Annual Review of Public HealthCompeting Risks in Mortality Analysis
112 Citations1991Chin Long Chiang
A brief review of the concept of competing risks and the statistical methods of mortality analysis including estimation of three types of probability of dying with respect to a particular cause of death and formulas of estimates for cohort studies medical follow-up studies and analyses of mortality data for a current population.
PubMedEvaluation of the effectiveness of immunization delivery methods.
112 Citations1995Theresa W. Gyorkos, T N Tannenbaum +8 more
This review of the scientific evidence of the effectiveness of immunization delivery methods provides a base for policy development and assists in the planning of resource allocation.
American Journal of Public HealthPneumococcal bacteremia in Monroe County, New York.
108 Citations1992Nancy M. Bennett, Joanna Buffington +1 more
This study documents the incidence of and mortality from pneumococcal bacteremia in Monroe County, New York, from 1985 through 1989 and supports previous observations that Black populations have an increased risk of invasive pneumococCal infection and suggests that immunization should be considered for Blacks older than 55 years.
Archives of Internal MedicineThe Pneumococcal Vaccine After 15 Years of Use
105 Citations1994Jan V. Hirschmann
Since the vaccine's release, many groups, including the Immunization Practice Advisory Committee sponsored by the US Public Health Service, have endorsed a nationwide vaccination program for people with increased susceptibility to pneumococcal disease.
The Journal of Infectious DiseasesInvasive Disease Due to Streptococcus pneumoniae in an Area with a High Rate of Relative Penicillin Resistance
89 Citations1987G R Istre, Martha Tarpay +4 more
During 1984, a population-based survey of culture-confirmed invasive disease due to Streptococcus pneumoniae among persons who lived in the Oklahoma City, Oklahoma, metropolitan area through the 20 clinical laboratories found rates were highest among infants less than 12 months old and persons greater than or equal to 80 years old.
JAMAInvasive Pneumococcal Disease in an Alaska Native Population, 1980 Through 1986
89 Citations1989Michael Davidson
From 1980 through 1986, one hundred fourteen Alaska Native patients from the Yukon-Kuskokwim Delta had community-acquired invasive pneumococcal disease confirmed by isolates of Streptococcus pneumoniae from normally sterile body sites.
JAMAHospital-Based Pneumococcal Immunization
75 Citations1990David S. Fedson
Analysis of a population-based linked record of hospital discharges for Medicare enrollees living in the Shenandoah region of Virginia provides an epidemiologic rationale for current recommendations that elderly patients discharged from hospitals should be immunized with pneumococcal vaccine.
Annals of Internal MedicineConfronting Drug-resistant Pneumococci
71 Citations1994Robert Austrian
It is probably a truism that, if mutants of an organism resistant to an antibacterial agent can be isolated in the laboratory, sooner or later similar resistant mutants will be isolated from humans, although protracted periods of time may elapse between the two observations.
Archives of Internal MedicinePneumococcal Vaccine After 15 Years of Use
64 Citations1994David S. Fedson
The evidence justifies not vaccinating immunocompromised or elderly populations with pneumococcal vaccine, according to Hirschmann and Lipsky.
Clinics in Geriatric MedicineClinical Practice and Public Policy for Influenza and Pneumococcal Vaccination of the Elderly
61 Citations1992David S. Fedson
Adequate reimbursement by Medicare and other third-party payers needs to be supplemented by educational programs to promote influenza and pneumococcal vaccines if the opportunity vaccination presents to improve the health and well-being of elderly persons is to be fully realized.
The Journal of Infectious DiseasesCost-Effectiveness and Cost-Benefit Analyses of Vaccines
48 Citations1981Jane Sisk Willems, Charles Richard Sanders
PubMedPneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
33 Citations1993D S Fedson
It is not necessary to know whether the vaccine is clinically effective or cost-effective in preventing pneumococcal pneumonia in order to know how to manage patients, but it is indicated for all older, high-risk patients.
Archives of Internal MedicineThe Utilization of Pneumococcal Polysaccharide Vaccine Among Elderly Medicare Beneficiaries, 1985 Through 1988
31 Citations1991A. Marshall McBean
Crude 4-year rates indicated that white persons were much more likely to be immunized than black persons and Persons 70 through 84 years of age had higher immunization rates than either younger or older beneficiaries.
PubMedPneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
22 Citations1993Michael S. Simberkoff
I concur with the recommendations for use of pneumococcal vaccine to prevent bacteremia, but I am skeptical about the vaccine's efficacy against pneumonia.
Journal of Clinical MicrobiologySerotypes of Streptococcus pneumoniae blood culture isolates from adults in Franklin County, Ohio
20 Citations1994Joseph F. Plouffe, Sheila Moore +2 more
Isolates of Streptococcus pneumoniae in cultures of blood from 258 adults seen in 10 Franklin County, Ohio, hospitals from 1991 and 1992 were serotyped, and most strains belonged to serotypes that are included in the current pneumococcal vaccine.
PubMedPneumococcal bacteremia in Hawaii: initial findings of a pneumococcal disease prevention project.
14 Citations1989Campbell Jf, Donohue Ma +3 more
It is confirmed that pneumococcal bacteremia causes significant morbidity and mortality among elderly residents of Hawaii and suggests that vaccine coverage is very low among this high-risk population and the overall case-fatality rate in this study was relatively low.
PubMedFeedback of clinical performance information.
10 Citations1993Schoenbaum Sc
This paper discusses how the content of the information and the process of the feedback itself can facilitate physicians' buying into and using the data to improve practice.